Moa of metronidazole

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Excellent - I have rich textbook content. Let me now compile the comprehensive answer.

Mechanism of Action of Metronidazole

Metronidazole is a nitroimidazole antibiotic and antiprotozoal. Its MOA hinges on selective toxicity - it is essentially a prodrug that must be activated inside susceptible organisms.

Step-by-Step Mechanism

1. Intracellular uptake Metronidazole enters the cell by passive diffusion. It distributes widely - achieving therapeutic concentrations in vaginal fluid, seminal fluid, saliva, CSF, and breast milk.
2. Reductive activation (the key step) Inside anaerobic bacteria and sensitive protozoans (e.g., E. histolytica, Giardia, Trichomonas), the drug's nitro group (-NO₂) is chemically reduced by:
  • Ferredoxin-like, low-redox potential electron transport proteins present in anaerobes and susceptible parasites
  • These proteins act as electron donors, transferring electrons to the nitro group of metronidazole
This reduction generates reactive cytotoxic intermediates (nitroso radicals and hydroxylamine derivatives).
3. DNA damage The reduced cytotoxic products:
  • Bind to DNA (specifically to guanine and cytosine residues)
  • Cause loss of helical structure and strand breakage
  • Also inhibit DNA and RNA synthesis
  • Interfere with mitochondrial function and glucose metabolism
The result is cell death of the anaerobic organism or protozoan.

Why It Is Selective for Anaerobes

The critical selectivity comes from the fact that aerobic cells lack the low-redox-potential electron transport proteins (ferredoxins) needed to reduce the nitro group. In aerobic mammalian cells, the drug is not activated and therefore does not produce toxic intermediates. Only organisms with an anaerobic or microaerophilic metabolism can reduce metronidazole to its active, DNA-damaging form.

Summary Table

StepDetail
Drug classNitroimidazole (prodrug)
Activating agentFerredoxin-like low-redox electron transport proteins
Active toxic speciesReduced nitro intermediates (nitroso radicals)
Primary targetDNA (strand breakage, loss of helical structure)
Secondary effectsInhibition of DNA/RNA synthesis; disruption of mitochondrial function
Selectivity basisOnly anaerobic organisms and certain protozoans can reduce the nitro group

Spectrum of Activity (based on MOA)

The organisms that can activate metronidazole are the ones it kills:
  • Protozoans: Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis
  • Anaerobic bacteria: Bacteroides spp., anaerobic cocci, Clostridioides difficile, gram-positive anaerobic bacilli
It has no activity against aerobic or facultative organisms, which cannot reduce it.

Sources:
  • Katzung's Basic and Clinical Pharmacology, 16th Ed. - The nitro group is reduced in anaerobic bacteria and sensitive protozoans; reactive reduction products are responsible for antibacterial/antiprotozoal activity.
  • Lippincott Illustrated Reviews: Pharmacology - Ferredoxin-like low-redox potential electron transport proteins serve as electron acceptors; reduced cytotoxic compounds bind to proteins and DNA, causing trophozoite death.
  • Medical Microbiology 9e - Metronidazole binds to parasite guanine and cytosine residues, causing loss of helical structure and breakage of DNA strands; also inhibits DNA/RNA synthesis and mitochondrial function.

In summary

MOA of Metronidazole - Summary

Metronidazole is a prodrug (nitroimidazole) that requires activation inside anaerobic organisms.
  1. Entry - enters cells by passive diffusion
  2. Activation - the nitro group (-NO₂) is reduced by ferredoxin-like electron transport proteins found only in anaerobes/susceptible protozoans
  3. DNA damage - the resulting cytotoxic intermediates cause DNA strand breakage and loss of helical structure → cell death
Selectivity: Aerobic mammalian cells lack the low-redox ferredoxin proteins needed to activate the drug, so they are unaffected.
This is a shared conversation. Sign in to Orris to start your own chat.